Uni Super Management Pty LTD Regeneron Pharmaceuticals, Inc. Transaction History
Uni Super Management Pty LTD
- $15.9 Billion
- Q3 2025
A detailed history of Uni Super Management Pty LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Uni Super Management Pty LTD holds 9,559 shares of REGN stock, worth $6.63 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,559
Previous 8,368
14.23%
Holding current value
$6.63 Million
Previous $4.39 Million
22.33%
% of portfolio
0.03%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding REGN
# of Institutions
1,466Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...